Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction

References

• Lennert K., Mohri N., Stein H., Kaiserling E. The histopathology of malignant lymphoma. British Journal of Haematology 1975; 31: 193–203
   PubMed Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Kapanci Y., Kelényl G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., van Unnik J. A. M., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; i: 292, 293
   Google Scholar
• Lennert K., Feller A. C. Histopathologie der Non-Hodgkin-Lymphome (nach der aktuellen Kiel-Klassifikation). 2. Auflage. Springer, Berlin-Heidelberg-New York-London-Paris-Tokyo-Hong Kong 1990
   Google Scholar
• Lennert K., Tamm I. Histological and immunohistochemical differences between B-CLL and LP-immunocytoma. Abstracts of 5th International Workshop on CLL (Barcelona, 1991. 1991; 41
   Google Scholar
• Mayer R., Logtenberg T., Strauchen J., Dimitriu-Bona A., Mayer L., Mechanic S., Chiorazzi N., Borche L., Dighiero G., Mannheimer-Lory A., Diamond B., Alt F., Bona C. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood 1990; 75: 1518–1524
   PubMed Web of Science ®Google Scholar
• Han T., Sadamori N., Takeuchi J., Ozer H., Henderson E. S., Bhargava A., Fitzpatrick J., Sandberg A. A. Clonal chromosome abnormalities in patients with Aldenström's and CLL-associated macroglobulinemia: significance of trisomy 12. Blood 1983; 62: 525–531
   PubMed Web of Science ®Google Scholar
• Juliusson G., Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genetics and Cytogenetics 1990; 45: 143–160
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: new insights into biology and therapy. Annals of Internal Medicine 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Brittinger G., Bartels H., Common H., Dühmke E., Fülle H. H., Gunzer U., Gyenes T., Heinz R., König E., Meusers P., Paukstat M., Pralle H., Theml H., Köpcke W., Thieme C., Zwingers T., Musshoff K., Stacher A., Brücher H., Herrmann F., Ludwig W. D., Pribilla W., Burger-Schüller A., Löhr G. W., Gremmel H., Oertel J., Gerhartz H., Koeppen K.-M., Boll I., Huhn D., Binder T., Schoengen A., Nowicki L., Peeds H. W., Scheurlen P. G., Leopold H., Wannenmacher M., Schmidt M., Löffler H., Michlmayr G., Thiel E., Zettel R., Rühl U., Wilke H. J., Schwarze E.-W., Stein H., Feller A. C., Lennert K. (Kiel Lymphoma Study Group) Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematological Oncology 1984; 2: 269–306
   PubMedGoogle Scholar
• Brittinger G., Bartels H., Common H., Dühmke E., Engelhard M., Fülle H. H., Gunzer U., Gyenes T., Heinz R., König E., Meusers P., Pralle H., Theml H., Zwingers T., Musshoff K., Stacher A., Brücher H., Herrmann F., Ludwig W. D., Pribilla W., Burger-Schöler A., Löhr G. W., Gremmel H., Oertel J., Gerhartz H., Koeppen K.-M., Boll I., Huhn D., Binder T., Schoengen A., Nowicki I., Pees H. W., Scheurlen P. G., Leopold H., Wannenmacher M., Schmidt M., Löffler H., Michlmayr G., Thiel E., Zettel R., Röhl U., Wilke H. J., Schwarze E.-W., Stein H., Feller A. C., Lennert K. Klinische und prognostische Relevanz der Kiel-Klassifikation der Non-Hodgkin-Lymphome. Onkologie 1986; 9: 118–125
   PubMedGoogle Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Research 1971; 31: 1860, 1861
   PubMed Web of Science ®Google Scholar
• Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Binet J.-L., Catovsky D., Chandra P., Dighiero G., Montserrat E., Rai K. R., Sawitsky A. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL. British Journal of Haematology 1981; 48: 365–367
   PubMed Web of Science ®Google Scholar
• Knospe W. H., Loeb V., Jr., Huguley C. M., Jr. Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 1974; 33: 555–62
   PubMed Web of Science ®Google Scholar
• Bagley C. M., De Vita V. T., Jr., Berard C. W., Canellos G. P. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophsphamide, vincristine, and prednisone. Annals of Internal Medicine 1972; 76: 227, 234
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. Journal of The American Statistical Association 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 1966; 50: 163–170
   PubMedGoogle Scholar
• Cox D. R. Regression models and life tables. Journal of the Royal Statistical Society 1972; 34: 187–220, series B
   Google Scholar
• Vallespi T., Montserrat E., Sanz M. A. Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. British Journal of Haematology 1991; 77: 478–485
   PubMed Web of Science ®Google Scholar
• Rozman C., Montserrat E. Bone marrow biopsy in chronic lymphocytic leukaemia. Nouvelle Revue Française d'Hèmetologie 1988; 30: 369–371
   Web of Science ®Google Scholar
• Pangalis G. A., Boussiotis V. A., Kittas C. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern. Nouvelle Revue Française d'Hèmatologie 1988; 30: 373–375
   PubMedGoogle Scholar
• Raphael M., Debré P., Guigui B., Binet J.-L. Lymph node biopsy in chronic lymphocytic leukemia: prognostic significance of histopathological, morphometry and immunohistological findings. Nouvelle Revue Française d'Hématologie 1988; 30: 379–383
   PubMedGoogle Scholar
• Dadmarz R., Cawley J. C. Hereogeneity of CLL: high CD 23 antigen and αIFN receptor expression are features of favourable disease and of cell activation. British Journal of Haematology 1988; 68: a279–282
   PubMed Web of Science ®Google Scholar
• Gibson J., Neville S., Joshua D., Kronenberg H. CD 23 antigen expression in CLL. British Journal of Haematology 1989; 72: 598
   PubMed Web of Science ®Google Scholar
• Barnett D., Reilly J. T. Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL. British Journal of Haematology 1989; 73: 572
   PubMed Web of Science ®Google Scholar
• Orfao A., Gonzalez M., San Miguel J. F., Rios A., Canizo M. C., Hernandez J., Maricato M. L., Borrasca A. L. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features. American Journal of Hematology 1989; 31: 26–31
   PubMed Web of Science ®Google Scholar
• International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Annals of Internal Medicine 1989; 100: 236–238
   Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. Comparison of the (A, B, C) staging and the Rai's staging from a large prospective series (935 patients). Nouvelle Revue Française d'Hématologie 1988; 30: 363–367
   PubMedGoogle Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. Blood 1990; 75: 1414–21
   PubMed Web of Science ®Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlarambucil versus COP in stage B chronic lymphocytic leukemia. Blood 1990; 75: 1422, 1425
   PubMed Web of Science ®Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukaemia. Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. British Journal of Haematology. 1989; 73: 334–340
   PubMed Web of Science ®Google Scholar
• Richards M. A., Hall P. A., Gregory W. M., Dhaliwal H. S., Stansfeld A. G., Amess J. A. L., Lister T. A. Lymphoplasmacytoid and small cell centrocytic non-Hodgkin's lymphoma—a retrospective analysis from St. Bartholomew's Hospital 1972–1986. Hematological Oncology 1989; 7: 19–35
   PubMed Web of Science ®Google Scholar
• Young R. C., Longo D. L., Glatstein E., Ihde D. C., Jaffe E. S., DeVita V. T., Jr. The treatament of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Seminars in Hematology 1988; 25: 11–16, Suppl. 2
   PubMed Web of Science ®Google Scholar
• Jacobs P., King H. S. A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases. Blood 1987; 69: 1642–1646
   PubMed Web of Science ®Google Scholar
• Klapp R., Calavrezos A., Kuse R., Heilmann H. P. Risikoadaptierte Behandlung von Immuno-zytomen. Deutsche medizinische Wochenschrift 1987; 112: 1116–1120
   PubMed Web of Science ®Google Scholar
• Kimby E., Mellstedt H. Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemia of B-CLL type. Abstracts of 5th International Workshop on CLL (Barcelona 1991. 1991; 57
   Google Scholar
• AZiegler-Heitbrock H. W. L., Schlag R., Flieger D., Thiel E. Favorable response of early stage B CLL patients to treatment with IFN-α2. Blood 1989; 73: 1426–1430
   PubMed Web of Science ®Google Scholar
• Catovsky D., Fooks J., Richards S. Prognostic factors in chronic lymphocytic leukaemia: The importance of age, sex and response to treatment in survival. British Journal of Haematology 1989; 72: 141–149
   PubMed Web of Science ®Google Scholar
• Ben-Ezra J., Burke J. S., Swartz W. G., Brownell M. D., Brynes R. K., Hill L. R., Nathwani B. N., Oken M. M., Wolf B. C., Woodruff R., Rappaport H. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 1989; 73: 579–587
   PubMed Web of Science ®Google Scholar